Kocarnik, J. M., et al. (2022). Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: A systematic analysis for the global burden of disease study 2019. JAMA Oncology, 8(3), 420–444.

Article  PubMed  Google Scholar 

Brüggen, E. C., et al. (2017). Financial well-being: A conceptualization and research agenda. Journal of Business Research, 79, 228–237.

Article  Google Scholar 

Witte, J., et al. (2019). Methods for measuring financial toxicity after cancer diagnosis and treatment: A systematic review and its implications. Annals of Oncology, 30(7), 1061–1070.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fitch, M. I., et al. (2022). Experiencing financial toxicity associated with cancer in publicly funded healthcare systems: A systematic review of qualitative studies. Journal of Cancer Survivorship, 16(2), 314–328.

Article  PubMed  Google Scholar 

Udayakumar, S., et al. (2022). Cancer treatment-related financial toxicity experienced by patients in low- and middle-income countries: A scoping review. Supportive Care in Cancer, 30(8), 6463–6471.

Article  PubMed  Google Scholar 

Pangestu, S., & Rencz, F. (2023). Comprehensive score for Financial Toxicity and Health-related quality of life in patients with Cancer and survivors: A systematic review and Meta-analysis. Value In Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 26(2), 300–316.

Article  PubMed  Google Scholar 

Bhanvadia, S. K., et al. (2021). Financial toxicity among patients with prostate, bladder, and kidney Cancer: A systematic review and call to action. Eur Urol Oncol, 4(3), 396–404.

Article  PubMed  Google Scholar 

Ritter, J., et al. (2023). Financial hardship in families of children or adolescents with cancer: A systematic literature review. The Lancet Oncology, 24(9), e364–e375.

Article  PubMed  PubMed Central  Google Scholar 

Sitlinger, A., & Zafar, S. Y. (2018). Health-Related Quality of Life: The impact on morbidity and mortality. Surgical Oncology Clinics of North America, 27(4), 675–684.

Article  PubMed  PubMed Central  Google Scholar 

Azzani, M., et al. (2024). Subjective and objective financial toxicity among colorectal cancer patients: A systematic review. Bmc Cancer, 24(1), 40.

Article  PubMed  PubMed Central  Google Scholar 

Lueckmann, S. L., et al. (2022). Identifying missing links in the conceptualization of financial toxicity: A qualitative study. Supportive Care in Cancer, 30(3), 2273–2282.

Article  PubMed  Google Scholar 

Kang, D., et al. (2022). Impact of objective financial burden and subjective financial distress on spiritual well-being and quality of life among working-age cancer survivors. Supportive Care in Cancer, 30(6), 4917–4926.

Article  PubMed  Google Scholar 

de Souza, J. A., et al. (2017). Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive score for financial toxicity (COST). Cancer, 123(3), 476–484.

Article  PubMed  Google Scholar 

Head, B. A., & Faul, A. C. (2008). Development and validation of a scale to measure socioeconomic well-being in persons with cancer. The Journal of Supportive Oncology, 6(4), 183–192.

PubMed  Google Scholar 

Pangestu, S., et al. (2023). Financial toxicity experiences of patients with Cancer in Indonesia: An interpretive phenomenological analysis. Value Health Reg Issues, 41, 25–31.

Article  PubMed  Google Scholar 

Jiang, H., et al. (2023). Association between financial toxicity and health-related quality of life in cancer survivors: A systematic review. Asia Pac J Clin Oncol, 19(4), 439–457.

Article  PubMed  Google Scholar 

Zhu, Z., et al. (2020). Cancer survivors’ experiences with financial toxicity: A systematic review and meta-synthesis of qualitative studies. Psychooncology, 29(6), 945–959.

Article  PubMed  Google Scholar 

Zhu, Z., et al. (2022). Psychometric properties of self-reported financial toxicity measures in cancer survivors: A systematic review. British Medical Journal Open, 12(6), e057215.

Google Scholar 

Donkor, A., et al. (2022). Financial toxicity of cancer care in low- and middle-income countries: A systematic review and meta-analysis. Supportive Care in Cancer, 30(9), 7159–7190.

Article  PubMed  PubMed Central  Google Scholar 

Ehsan, A. N., et al. (2023). Financial toxicity among patients with breast Cancer Worldwide: A systematic review and Meta-analysis. JAMA Netw Open, 6(2), e2255388.

Article  PubMed  PubMed Central  Google Scholar 

Romero, M., Vivas-Consuelo, D., & Alvis-Guzman, N. (2013). Is Health Related Quality of Life (HRQoL) a valid indicator for health systems evaluation? Springerplus, 2(1), 664.

Article  PubMed  PubMed Central  Google Scholar 

Yin, S., et al. (2016). Summarizing health-related quality of life (HRQOL): Development and testing of a one-factor model. Popul Health Metr, 14, 22.

Article  PubMed  PubMed Central  Google Scholar 

Nutbeam, D., & Muscat, D. M. (2021). Health Promotion Glossary 2021. Health Promotion International, 36(6), 1578–1598.

Article  PubMed  Google Scholar 

Linton, M. J., Dieppe, P., & Medina-Lara, A. (2016). Review of 99 self-report measures for assessing well-being in adults: Exploring dimensions of well-being and developments over time. British Medical Journal Open, 6(7), e010641.

Google Scholar 

Yu, H. H., et al. (2021). The COmprehensive score for financial toxicity in China: Validation and responsiveness. J Pain Symptom Manage, 61(6), 1297–1304e1.

Article  PubMed  Google Scholar 

Cotlear, D., et al. (2015). Going universal: How 24 developing countries are implementing universal health coverage from the bottom up. World Bank.

Bray, F., et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. C Ca: A Cancer Journal for Clinicians, 68(6), 394–424.

Google Scholar 

Kosen, S. (2022). Coverage and implementation of healthcare delivery for cancer under national health insurance, experience of Indonesia. Lancet Reg Health Southeast Asia, 6, 100065.

Article  PubMed  PubMed Central  Google Scholar 

Ministry of Health of Republic of Indonesia. Health Research and Development Ethical Guidelines and Standards (In Indonesian) (2021). [cited 2024 January 18]; Available from: https://repository.badankebijakan.kemkes.go.id/id/eprint/4214/1/Pedoman%20dan%20Standar%20Etik%20Penelitian%20dan%20Pengembangan%20Kesehatan%20Nasional.pdf

Pangestu, S., et al. (2024). Validity, test-retest reliability, and responsiveness of the Indonesian version of FACIT-COST measure for subjective financial toxicity. Health and Quality of Life Outcomes, 22(1), 89.

Article  PubMed  PubMed Central  Google Scholar 

Pangestu, S. (2024). The Psychometric properties of the EQ-HWB and EQ-HWB-S in patients with breast Cancer: A comparative analysis with EQ-5D-5L, FACT-8D, and SWEMWBS. Value In Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, Online ahead of print.

Herdman, M., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Purba, F. D., et al. (2017). The Indonesian EQ-5D-5L Value Set. Pharmacoeconomics, 35(11), 1153–1165.

Article  PubMed  PubMed Central  Google Scholar 

Shim, S., et al. (2022). Validation of Korean Version of the COmprehensive score for financial toxicity (COST) among breast Cancer survivors. Cancer Res Treat, 54(3), 834–841.

Article  PubMed  Google Scholar 

Sagberg, L. M., Jakola, A. S., & Solheim, O. (2014). Quality of life assessed with EQ-5D in patients undergoing glioma surgery: What is the responsiveness and minimal clinically important difference? Quality of Life Research, 23(5), 1427–1434.

Article  PubMed  Google Scholar 

Zeng, X., et al. (2021). Measurement Properties of the EQ-5D-5L and EQ-5D-3L in six commonly diagnosed cancers. Patient, 14(2), 209–222.

Article  PubMed  Google Scholar 

Zhu, J., et al. (2021). Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: Suggestions for instrument choosing. Quality of Life Research, 30(3), 841–854.

Article  PubMed  Google Scholar 

Brazier,